Mandate

Vinge advises EQT Infrastructure in connection with its divestment of a minority stake in GlobalConnect to Mubadala

Vinge advises EQT Infrastructure III and IV funds (“EQT Infrastructure”) in connection with their divestment of a minority stake in the GlobalConnect group (“GlobalConnect”) to Mubadala Investment Company (“Mubadala”). Having been invested in GlobalConnect since 2017, EQT Infrastructure will remain as the largest shareholder following the closing of the transaction.

GlobalConnect is a fiber-based data communication and data centre services provider to enterprises, public institutions, and consumers in Northern Europe. GlobalConnect’s infrastructure carries more than 50 percent of all internet traffic generated in the Nordics across its network of 150,000 km of fiber infrastructure and 35,000 m2 data centre space, and employs approx. 1,800 people in the region.

By welcoming Mubadala as a minority investor in GlobalConnect, EQT Infrastructure aims to broaden GlobalConnect's long-term shareholder base, while drawing on Mubadala’s prior investment experience in data centre and Fiber-to-the-Home assets in numerous markets.

The transaction is subject to customary conditions and approvals, and is expected to be completed in Q1 2023.

Vinge’s team consisted of Daniel Rosvall, Maria Dahlin Kolvik, Karl Klackenberg, Desirée Hagenfeldt, Viktor Lennartsson, Nina Gransäter, Amanda Steen and Sebastian Saadieh (M&A), Lisa Hörnqvist and Mathilda Persson (Commercial Agreements), Daniel Wendelsson and Victoria Fredén (FDI), Sebastian Örndahl (Antitrust and Telecom Regulatory), Tove Tullberg (Compliance), Axel Jansson and Ida Redander (Banking and Finance), Axel Lennartsson (IP), Kristoffer Larson (Real Estate), Sara Strandberg (Employment), and Sara Dahlros Sköld, Emy Rydén, Julia Hagelberg and Christoffer Widström (VDR).

 

Related

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.
January 12, 2026